The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARALEZ PHARMACEUTICALS INC COM 03852X100 4,651 958,945 SH   DFND   958,945 0 0
CUTERA INC COM 232109108 626 52,500 SH   DFND   52,500 0 0
NEOTHETICS INC COM 64066G101 1,493 1,333,000 SH   DFND   1,333,000 0 0
RADIANT LOGISTICS INC COM 75025X100 1,128 397,100 SH   DFND   397,100 0 0
ROKA BIOSCIENCE INC COM 775431109 282 405,500 SH   DFND   405,500 0 0
SPIRIT AIRLS INC COM 848577102 425 10,000 SH   DFND   10,000 0 0
SYNERON MEDICAL LTD ORD SHS M87245102 12,172 1,700,000 SH   DFND   1,700,000 0 0
VIVEVE MED INC COM NEW 92852W204 343 47,434 SH   DFND   47,434 0 0
ZELTIQ AESTHETICS INC COM 98933Q108 3,263 83,200 SH   DFND   83,200 0 0